10 November 2021 | News
The net sales for the quarter is at Rs 1292 crore
Image Credit: Shutterstock
Alembic Pharmaceuticals reported its consolidated financial results for the quarter ending September 30, 2021. The net sales for the quarter is at Rs 1292 crore, net profit at Rs 169 crore, net sales for H-1 FY21 has been reported at Rs 2618 crore and the net profit for H-1 FY21 at Rs 334 crores.
Shaunak Amin, MD, Alembic Pharmaceuticals said, “The India branded formulation business has posted a strong growth rate for the second consecutive quarter. This is attributed to the consistent efforts to redefine our business strategy and customer relationships, leading to a strong operational performance, along with a market outperforming growth across all our key product segments and therapy areas.”